• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膜通透性和系统参数对血液透析清除蛋白结合尿毒症毒素的影响。

Effect of Membrane Permeance and System Parameters on the Removal of Protein-Bound Uremic Toxins in Hemodialysis.

机构信息

Department of Chemical Engineering, Massachusetts Institute of Technology, 25 Ames St, Cambridge, MA, 02142, USA.

Department of Mechanical Engineering, Massachusetts Institute of Technology, 77 Massachusetts Ave, Cambridge, MA, 02139, USA.

出版信息

Ann Biomed Eng. 2024 Mar;52(3):526-541. doi: 10.1007/s10439-023-03397-6. Epub 2023 Nov 22.

DOI:10.1007/s10439-023-03397-6
PMID:37993752
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10859350/
Abstract

Inadequate clearance of protein-bound uremic toxins (PBUTs) during dialysis is associated with morbidities in chronic kidney disease patients. The development of high-permeance membranes made from materials such as graphene raises the question whether they could enable the design of dialyzers with improved PBUT clearance. Here, we develop device-level and multi-compartment (body) system-level models that account for PBUT-albumin binding (specifically indoxyl sulfate and p-cresyl sulfate) and diffusive and convective transport of toxins to investigate how the overall membrane permeance (or area) and system parameters including flow rates and ultrafiltration affect PBUT clearance in hemodialysis. Our simulation results indicate that, in contrast to urea clearance, PBUT clearance in current dialyzers is mass-transfer limited: Assuming that the membrane resistance is dominant, raising PBUT permeance from 3 × 10 to 10 m s (or equivalently, 3.3 × increase in membrane area from ~ 2 to ~ 6 m) increases PBUT removal by 48% (from 22 to 33%, i.e., ~ 0.15 to ~ 0.22 g per session), whereas increasing dialysate flow rates or adding adsorptive species have no substantial impact on PBUT removal unless permeance is above ~ 10 m s. Our results guide the future development of membranes, dialyzers, and operational parameters that could enhance PBUT clearance and improve patient outcomes.

摘要

在透析过程中,蛋白质结合尿毒症毒素 (PBUT) 的清除不足与慢性肾脏病患者的发病率有关。由石墨烯等材料制成的高通量膜的发展提出了一个问题,即它们是否能够设计出具有改善 PBUT 清除率的透析器。在这里,我们开发了设备级和多腔(体)系统级模型,这些模型考虑了 PBUT-白蛋白结合(特别是吲哚硫酸酯和对甲酚硫酸盐)以及毒素的扩散和对流传输,以研究整体膜通透性(或面积)和系统参数(包括流速和超滤)如何影响血液透析中的 PBUT 清除率。我们的模拟结果表明,与尿素清除率不同,当前透析器中的 PBUT 清除率受传质限制:假设膜阻力占主导地位,将 PBUT 通透性从 3×10 提高到 10 m s(或等效地,将膜面积从2 增加到6 m)将 PBUT 去除率提高 48%(从 22%提高到 33%,即每次透析从0.15 提高到0.22 g),而增加透析液流速或添加吸附物质除非通透性高于~10 m s,否则对 PBUT 去除率没有实质性影响。我们的结果指导了未来的膜、透析器和操作参数的发展,这些发展可以提高 PBUT 的清除率并改善患者的预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed3e/10859350/87be68bfa31c/10439_2023_3397_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed3e/10859350/715ad0e42687/10439_2023_3397_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed3e/10859350/46cb44ed69f6/10439_2023_3397_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed3e/10859350/fcff1c13d28f/10439_2023_3397_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed3e/10859350/bac79135beb3/10439_2023_3397_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed3e/10859350/89176a472cc7/10439_2023_3397_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed3e/10859350/27172ac28dce/10439_2023_3397_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed3e/10859350/87be68bfa31c/10439_2023_3397_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed3e/10859350/715ad0e42687/10439_2023_3397_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed3e/10859350/46cb44ed69f6/10439_2023_3397_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed3e/10859350/fcff1c13d28f/10439_2023_3397_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed3e/10859350/bac79135beb3/10439_2023_3397_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed3e/10859350/89176a472cc7/10439_2023_3397_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed3e/10859350/27172ac28dce/10439_2023_3397_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed3e/10859350/87be68bfa31c/10439_2023_3397_Fig7_HTML.jpg

相似文献

1
Effect of Membrane Permeance and System Parameters on the Removal of Protein-Bound Uremic Toxins in Hemodialysis.膜通透性和系统参数对血液透析清除蛋白结合尿毒症毒素的影响。
Ann Biomed Eng. 2024 Mar;52(3):526-541. doi: 10.1007/s10439-023-03397-6. Epub 2023 Nov 22.
2
Protein-Bound Uremic Toxins in Hemodialysis Patients Relate to Residual Kidney Function, Are Not Influenced by Convective Transport, and Do Not Relate to Outcome.血液透析患者的蛋白结合型尿毒症毒素与残余肾功能相关,不受对流传输影响,与预后无关。
Toxins (Basel). 2020 Apr 7;12(4):234. doi: 10.3390/toxins12040234.
3
Protein-bound uremic toxins (PBUTs) in chronic kidney disease (CKD) patients: Production pathway, challenges and recent advances in renal PBUTs clearance.慢性肾脏病(CKD)患者体内的蛋白结合型尿毒症毒素(PBUTs):产生途径、面临的挑战及肾脏 PBUTs 清除的最新进展。
NanoImpact. 2021 Jan;21:100299. doi: 10.1016/j.impact.2021.100299. Epub 2021 Jan 28.
4
A novel mathematical model of protein-bound uremic toxin kinetics during hemodialysis.一种新型的血液透析过程中蛋白结合尿毒症毒素动力学的数学模型。
Sci Rep. 2017 Sep 4;7(1):10371. doi: 10.1038/s41598-017-10981-z.
5
Adsorption of Protein-Bound Uremic Toxins Through Direct Hemoperfusion With Hexadecyl-Immobilized Cellulose Beads in Patients Undergoing Hemodialysis.在接受血液透析的患者中,通过用十六烷基固定化纤维素珠进行直接血液灌流吸附蛋白结合型尿毒症毒素。
Artif Organs. 2018 Jan;42(1):88-93. doi: 10.1111/aor.12961. Epub 2017 Jul 13.
6
Using binding competitors of albumin to promote the removal of protein-bound uremic toxins in hemodialysis: Hope or pipe dream?使用与白蛋白结合的竞争物促进血液透析中蛋白结合型尿毒症毒素的清除:希望还是白日梦?
Biochimie. 2018 Jan;144:1-8. doi: 10.1016/j.biochi.2017.09.018. Epub 2017 Oct 5.
7
Detailing Protein-Bound Uremic Toxin Interaction Mechanisms with Human Serum Albumin in the Pursuit of Designing Competitive Binders.解析蛋白结合尿毒症毒素与人体血清白蛋白相互作用机制,设计竞争结合物。
Int J Mol Sci. 2023 Apr 18;24(8):7452. doi: 10.3390/ijms24087452.
8
Removal of Protein-Bound Uremic Toxins during Hemodialysis Using a Binding Competitor.使用结合竞争剂去除血液透析中的蛋白结合型尿毒症毒素。
Clin J Am Soc Nephrol. 2019 Mar 7;14(3):394-402. doi: 10.2215/CJN.05240418. Epub 2019 Feb 12.
9
Exploring binding characteristics and the related competition of different protein-bound uremic toxins.探索不同蛋白结合型尿毒症毒素的结合特性及相关竞争性。
Biochimie. 2017 Aug;139:20-26. doi: 10.1016/j.biochi.2017.05.010. Epub 2017 May 17.
10
Improved dialytic removal of protein-bound uremic toxins by intravenous lipid emulsion in chronic kidney disease rats.静脉用脂肪乳剂增强慢性肾脏病大鼠对蛋白结合型尿毒症毒素的透析清除。
Nephrol Dial Transplant. 2019 Nov 1;34(11):1842-1852. doi: 10.1093/ndt/gfz079.

引用本文的文献

1
Autologous platelet-rich plasma therapy for skin ulceration due to calcific uremic arteriopathy: a case report and review of the literature.自体富血小板血浆治疗钙化性尿毒症性动脉病所致皮肤溃疡:1例报告并文献复习
Int Urol Nephrol. 2025 Apr 12. doi: 10.1007/s11255-025-04502-5.

本文引用的文献

1
Detailing Protein-Bound Uremic Toxin Interaction Mechanisms with Human Serum Albumin in the Pursuit of Designing Competitive Binders.解析蛋白结合尿毒症毒素与人体血清白蛋白相互作用机制,设计竞争结合物。
Int J Mol Sci. 2023 Apr 18;24(8):7452. doi: 10.3390/ijms24087452.
2
Nonlinear ion transport mediated by induced charge in ultrathin nanoporous membranes.超薄纳米多孔膜中感应电荷介导的非线性离子传输。
Phys Rev E. 2021 Oct;104(4-1):044802. doi: 10.1103/PhysRevE.104.044802.
3
Rapid screening of nanopore candidates in nanoporous single-layer graphene for selective separations using molecular visualization and interatomic potentials.
利用分子可视化和原子间势对纳米多孔单层石墨烯中的纳米孔候选物进行快速筛选,以实现选择性分离。
J Chem Phys. 2021 May 14;154(18):184111. doi: 10.1063/5.0044041.
4
Removal of Protein-Bound Uremic Toxins during Hemodialysis Using a Binding Competitor.使用结合竞争剂去除血液透析中的蛋白结合型尿毒症毒素。
Clin J Am Soc Nephrol. 2019 Mar 7;14(3):394-402. doi: 10.2215/CJN.05240418. Epub 2019 Feb 12.
5
Enhanced Removal of Protein-Bound Uremic Toxins Using Displacers: Road to Success?使用置换剂增强蛋白质结合型尿毒症毒素的清除:成功之路?
Clin J Am Soc Nephrol. 2019 Mar 7;14(3):324-326. doi: 10.2215/CJN.00500119. Epub 2019 Feb 6.
6
In silico comparison of protein-bound uremic toxin removal by hemodialysis, hemodiafiltration, membrane adsorption, and binding competition.通过血液透析、血液透析滤过、膜吸附和结合竞争对蛋白质结合尿毒症毒素的清除进行计算机模拟比较。
Sci Rep. 2019 Jan 29;9(1):909. doi: 10.1038/s41598-018-37195-1.
7
Increasing the removal of protein-bound uremic toxins by liposome-supported hemodialysis.通过脂质体支持的血液透析增加蛋白结合型尿毒症毒素的清除率。
Artif Organs. 2019 May;43(5):490-503. doi: 10.1111/aor.13383. Epub 2018 Dec 12.
8
Membrane innovation: closer to native kidneys.膜创新:更接近天然肾脏。
Nephrol Dial Transplant. 2018 Oct 1;33(suppl_3):iii22-iii27. doi: 10.1093/ndt/gfy228.
9
Haemodialysis membranes.血液透析膜。
Nat Rev Nephrol. 2018 Jun;14(6):394-410. doi: 10.1038/s41581-018-0002-x.
10
A Scalable Route to Nanoporous Large-Area Atomically Thin Graphene Membranes by Roll-to-Roll Chemical Vapor Deposition and Polymer Support Casting.卷对卷化学气相沉积和聚合物支撑铸膜法制备大面积原子级薄纳米多孔石墨烯膜的可扩展途径。
ACS Appl Mater Interfaces. 2018 Mar 28;10(12):10369-10378. doi: 10.1021/acsami.8b00846. Epub 2018 Mar 19.